Works matching AU Jia, Jidong

Results: 123
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Identification of potential modifier genes in Chinese patients with Wilson disease.

    Published in:
    Metallomics, 2022, v. 14, n. 5, p. 1, doi. 10.1093/mtomcs/mfac024
    By:
    • Zhou, Donghu;
    • Jia, Siyu;
    • Yi, Liping;
    • Wu, Zhen;
    • Song, Yi;
    • Zhang, Bei;
    • Li, Yanmeng;
    • Yang, Xiaoxi;
    • Xu, Anjian;
    • Li, Xiaojin;
    • Zhang, Wei;
    • Duan, Weijia;
    • Li, Zhenkun;
    • Qi, Saiping;
    • Chen, Zhibin;
    • Ouyang, Qin;
    • Jia, Jidong;
    • Huang, Jian;
    • Ou, Xiaojuan;
    • You, Hong
    Publication type:
    Article
    17
    18

    Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.

    Published in:
    Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1648, doi. 10.7326/M23-2391
    By:
    • Awan, Ahmed Arslan Yousuf;
    • Berenguer, Marina C.;
    • Bruchfeld, Annette;
    • Fabrizi, Fabrizio;
    • Goldberg, David S.;
    • Jia, Jidong;
    • Kamar, Nassim;
    • Mohamed, Rosmawati;
    • Pessôa, Mário Guimarães;
    • Pol, Stanislas;
    • Sise, Meghan E.;
    • Balk, Ethan M.;
    • Gordon, Craig E.;
    • Adam, Gaelen;
    • Cheung, Michael;
    • Earley, Amy;
    • Martin, Paul;
    • Jadoul, Michel
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    East Asia expert opinion on treatment initiation for chronic hepatitis B.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 10, p. 1540, doi. 10.1111/apt.16097
    By:
    • Kao, Jia‐Horng;
    • Hu, Tsung‐Hui;
    • Jia, Jidong;
    • Kurosaki, Masayuki;
    • Lim, Young‐Suk;
    • Lin, Han‐Chieh;
    • Sinn, Dong Hyun;
    • Tanaka, Yasuhito;
    • Wai‐Sun Wong, Vincent;
    • Yuen, Man‐Fung
    Publication type:
    Article
    35

    A missense variant in complement factor B (CFB) is a potential predictor of 24‐week off‐treatment response to PegIFNα therapy in Chinese HBeAg‐positive chronic hepatitis B patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 4, p. 469, doi. 10.1111/apt.15624
    By:
    • Chen, Haitao;
    • Sun, Jian;
    • Zhou, Bin;
    • Peng, Jinxin;
    • Xie, Qing;
    • Liang, Xieer;
    • Fan, Rong;
    • Conran, Carly;
    • Xu, Jianfeng;
    • Ji, Yuan;
    • Zhang, Xinxin;
    • Sun, Li;
    • Jia, Jidong;
    • Wang, Guiqiang;
    • Hou, Jinlin;
    • Jiang, De‐Ke;
    • Wang, Hao;
    • Bai, Xuefan;
    • Cheng, Jun;
    • Niu, Junqi
    Publication type:
    Article
    36
    37
    38

    Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study.

    Published in:
    Infection & Drug Resistance, 2019, v. 12, p. 745, doi. 10.2147/IDR.S185120
    By:
    • Wu, Xiaoning;
    • Zhou, Jialing;
    • Xie, Wen;
    • Ding, Huiguo;
    • Ou, Xiaojuan;
    • Chen, Guofeng;
    • Ma, Anlin;
    • Xu, Xiaoyuan;
    • Ma, Hui;
    • Xu, Youqing;
    • Liu, Xiaoqing;
    • Meng, Tongtong;
    • Wang, Lin;
    • Sun, Yameng;
    • Wang, Bingqiong;
    • Kong, Yuanyuan;
    • Ma, Hong;
    • You, Hong;
    • Jia, Jidong
    Publication type:
    Article
    39
    40
    41

    Investment Case for a Comprehensive Package of Interventions Against Hepatitis B in China: Applied Modeling to Help National Strategy Planning.

    Published in:
    Clinical Infectious Diseases, 2021, v. 72, n. 5, p. 743, doi. 10.1093/cid/ciaa134
    By:
    • Nayagam, Shevanthi;
    • Chan, Polin;
    • Zhao, Kun;
    • Sicuri, Elisa;
    • Wang, Xiaochun;
    • Jia, Jidong;
    • Wei, Lai;
    • Walsh, Nick;
    • Rodewald, Lance E;
    • Zhang, Guomin;
    • Ailing, Wang;
    • Zhang, Lan;
    • Chang, Joo H;
    • Hou, WeiWei;
    • Qiu, Yingpeng;
    • Sui, Binyan;
    • Xiao, Yue;
    • Zhuang, Hui;
    • Thursz, M R;
    • Scano, Fabio
    Publication type:
    Article
    42
    43
    44
    45
    46
    47

    The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.

    Published in:
    Clinical Reviews in Allergy & Immunology, 2018, v. 54, n. 2, p. 282, doi. 10.1007/s12016-017-8655-y
    By:
    • Yao, Mingjie;
    • Wang, Leijie;
    • Leung, Patrick S. C.;
    • Li, Yanmei;
    • Liu, Shuhong;
    • Wang, Lu;
    • Guo, Xiaodong;
    • Zhou, Guangde;
    • Yan, Ying;
    • Guan, Guiwen;
    • Chen, Xiangmei;
    • Bowlus, Christopher L.;
    • Liu, Tianhui;
    • Jia, Jidong;
    • Gershwin, M. Eric;
    • Ma, Xiong;
    • Zhao, Jingmin;
    • Lu, Fengmin
    Publication type:
    Article
    48
    49

    Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single‐arm, open‐label, phase 3 trial.

    Published in:
    Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 9, p. 2375, doi. 10.1111/jgh.15412
    By:
    • Kong, Fei;
    • Wen, Xiaoyu;
    • Wen, Xiaofeng;
    • Wang, Xiaozhong;
    • Wu, Guicheng;
    • Lin, Shide;
    • Wang, Li;
    • Xing, Huichun;
    • Yan, Xuebing;
    • Zheng, Sujun;
    • Ning, Qin;
    • Wang, Zheng;
    • Zhang, Liaoyun;
    • Lin, Jianmei;
    • Tong, Zhaowei;
    • Huang, Chengyu;
    • Su, Minghua;
    • Tong, Lixin;
    • Jia, Jidong;
    • Xin, Yongning
    Publication type:
    Article
    50